Insider Ledger
INKT insider buying and SEC filings, explained
MiNK Therapeutics, Inc. · CIK 1840229
Tracked: Forms 3/4/5, 8-K, NT · All filings on sec.gov
Company profile
- Exchanges
- Nasdaq
- Industry (SIC)
- Biological Products, (No Diagnostic Substances)
- State of incorporation
- DE
- Fiscal year end
- Dec 31
- Former names
- AgenTus Therapeutics, Inc.; AgenTus Therapeutics, Inc.
Insider activity in the last 12 months
Bought
$0
Insiders who bought
0
Sold (not marked 10b5-1)
$120K
Planned sales (10b5-1)
$0
Insider purchases and sales, last 12 months
| Traded | Type | What was filed | Source |
|---|---|---|---|
| Oct 12, 2026 | Sale | Jennifer Buell (CEO and Director) sold 6,938 shares at about $10.56 ($73K). Holdings down 9% to 74,195 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Oct 14, 2026, 2:36 PM ET |
| Jun 4, 2026 | Sale | Barbara Ryan (Director) sold 1,500 shares at about $12.76 ($19K). Holdings down 6% to 21,969 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jun 5, 2026 |
| Mar 9–10, 2026 | Sale | Barbara Ryan (Director) sold 1,500 shares between Mar 9 and Mar 10 at about $14.70 ($22K). Holdings down 7% to 20,406 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Mar 11, 2026 |
| Feb 27–Mar 2, 2026 | Sale | Barbara Ryan (Director) sold 500 shares between Feb 27 and Mar 2 at about $10.85 ($5K). Holdings down 2% to 21,906 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Mar 4, 2026 |
23 routine transactions (such as grants, option exercises or tax withholding) are not listed.
Cluster buys
No cluster buys in the last 12 months.
Red flags
No red flags in the last 12 months.
Key events
No key events in the last 12 months.
8-K filings, last 12 months
No 8-K filings in the last 12 months.
Red flags are objective triggers only: the item or form filed, never an opinion.
Follow INKT in the Insider Ledger app
Get the appA plain-English brief of insider purchases, 8-Ks and red flags at the companies you pick. No account needed.